Leon De Waal

Dr. Leon De Waal


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2016 in Viruses
Verified
Journal Article
Open access
PDF file
KSKoert J. Stittelaar
Koert J. Stittelaar
LWLeon De Waal
Leon De Waal
GAGeert Van Amerongen
Geert Van Amerongen
EKEdwin J.B. Veldhuis Kroeze
Edwin J.B. Veldhuis Kroeze
PFPieter L.A. Fraaij
Pieter L.A. Fraaij
RSRik L. de Swart
Rik L. de Swart
Human respiratory syncytial virus (HRSV) is an important cause of severe respiratory tract disease in immunocompromised patients. Animal models are indispensable for evaluating novel intervention strategies in this complex patient population. To complement existing models in rodents and non-human primates, we have evaluated the potential benefits of an HRSV infection model in ferrets (Mustela putorius furo). Nine- to 12-month-old HRSV-seronegative immunocompetent or immunocompromised ferrets were infected with a low-passage wild-type strain of HRSV subgroup A (105 TCID50) administered by intra-tracheal or intra-nasal inoculation. Immune suppression was achieved by bi-daily oral administration of tacrolimus, mycophenolate mofetil, and prednisolone. Throat and nose swabs were collected daily and animals were euthanized four, seven, or 21 days post-infection (DPI). Virus loads were determined by quantitative virus culture and qPCR. We observed efficient HRSV replication in both the upper and lower respiratory tract. In immunocompromised ferrets, virus loads reached higher levels and showed delayed clearance as compared to those in immunocompetent animals. Histopathological evaluation of animals euthanized 4 DPI demonstrated that the virus replicated in the respiratory epithelial cells of the trachea, bronchi, and bronchioles. These animal models can contribute to an assessment of the efficacy and safety of novel HRSV intervention strategies.

27 August 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
AMAnna Z. Mykytyn
Anna Z. Mykytyn
MLMart Matthias Lamers
Mart Matthias Lamers
NONisreen Okba
Nisreen Okba
TBTim Immanuel Breugem
Tim Immanuel Breugem
DSDebby Schipper
Debby Schipper
BHBart Haagmans
Bart Haagmans
Transmission of severe acute respiratory coronavirus-2 (SARS-CoV-2) between livestock and humans is a potential public health concern. We demonstrate the susceptibility of rabbits to SARS-CoV-2, which excrete infectious virus from the nose and throat upon experimental inoculation. Therefore, investigations on the presence of SARS-CoV-2 in farmed rabbits should be considered.

2 January 2018 in Viruses
Verified
Journal Article
Open access
PDF file
LWLeon De Waal
Leon De Waal
SSSaskia Smits
Saskia Smits
EKEdwin J.B. Veldhuis Kroeze
Edwin J.B. Veldhuis Kroeze
GAGeert Van Amerongen
Geert Van Amerongen
MPMarie O. Pohl
Marie O. Pohl
KSKoert J. Stittelaar
Koert J. Stittelaar
Human respiratory syncytial virus (HRSV) causes substantial morbidity and mortality in vulnerable patients, such as the very young, the elderly, and immunocompromised individuals of any age. Nosocomial transmission of HRSV remains a serious challenge in hospital settings, with intervention strategies largely limited to infection control measures, including isolation of cases, high standards of hand hygiene, cohort nursing, and use of personal protective equipment. No vaccines against HRSV are currently available, and treatment options are largely supportive care and expensive monoclonal antibody or antiviral therapy. The limitations of current animal models for HRSV infection impede the development of new preventive and therapeutic agents, and the assessment of their potential for limiting HRSV transmission, in particular in nosocomial settings. Here, we demonstrate the efficient transmission of HRSV from immunocompromised ferrets to both immunocompromised and immunocompetent contact ferrets, with pathological findings reproducing HRSV pathology in humans. The immunocompromised ferret-HRSV model represents a novel tool for the evaluation of intervention strategies against nosocomial transmission of HRSV.

24 April 2019 in Viruses
Verified
Journal Article
Open access
PDF file
WWWidagdo Widagdo
Widagdo Widagdo
NONisreen Okba
Nisreen Okba
MRMathilde Richard
Mathilde Richard
DMDennis de Meulder
Dennis de Meulder
TBTheo M. Bestebroer
Theo M. Bestebroer
SHSander Herfst
Sander Herfst
Middle East respiratory syndrome coronavirus (MERS-CoV) transmission from dromedaries to humans has resulted in major outbreaks in the Middle East. Although some other livestock animal species have been shown to be susceptible to MERS-CoV, it is not fully understood why the spread of the virus in these animal species has not been observed in the field. In this study, we used rabbits to further characterize the transmission potential of MERS-CoV. In line with the presence of MERS-CoV receptor in the rabbit nasal epithelium, high levels of viral RNA were shed from the nose following virus inoculation. However, unlike MERS-CoV-infected dromedaries, these rabbits did not develop clinical manifestations including nasal discharge and did shed only limited amounts of infectious virus from the nose. Consistently, no transmission by contact or airborne routes was observed in rabbits. Our data indicate that despite relatively high viral RNA levels produced, low levels of infectious virus are excreted in the upper respiratory tract of rabbits as compared to dromedary camels, thus resulting in a lack of viral transmission.